Fluorescence-based functional assay for Wnt/β-catenin signaling activity

BioTechniques

Volumn 33, Issue 5, 2002, Pages 1126-1135

  Zhou, L ^a   An, N ^a   Jiang, W ^a   Haydon, R ^a   Cheng, H ^a   Zhou, Q ^a   Breyer, B ^a   Feng, T ^a   He, Tong Chuan ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOASSAY; CELLS; DNA; PROTEINS;

SIGNAL TRANSDUCERS;

TUMORS;

ANTINEOPLASTIC AGENT; BETA CATENIN; CHIMERIC PROTEIN; LITHIUM; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; WNT PROTEIN; CATNB PROTEIN, MOUSE; CTNNB1 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; GAL4 PROTEIN, S CEREVISIAE; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; LUCIFERASE; ONCOPROTEIN; PHOTOPROTEIN; SACCHAROMYCES CEREVISIAE PROTEIN; TUMOR PROTEIN; WNT1 PROTEIN; WNT1 PROTEIN, HUMAN; WNT1 PROTEIN, MOUSE; ZEBRAFISH PROTEIN;

ADENOVIRUS; ARTICLE; CARCINOGENESIS; CELL ACTIVATION; CELL LINE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG SCREENING; FLUORESCENCE ANALYSIS; GENE EXPRESSION SYSTEM; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PROTEIN DNA BINDING; PROTEIN STABILITY; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSACTIVATION; VIRUS RECOMBINANT; ADENOCARCINOMA; ANIMAL; BIOSYNTHESIS; BONE TUMOR; CELL CULTURE; CHONDROSARCOMA; COLON TUMOR; DRUG ANTAGONISM; FLUOROMETRY; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; KIDNEY; METHODOLOGY; MOUSE; OSTEOSARCOMA; PATHOLOGY; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

ADENOVIRIDAE;

ADENOCARCINOMA; ADENOVIRIDAE; ANIMALS; BETA CATENIN; BONE NEOPLASMS; CELL LINE; CHONDROSARCOMA; COLONIC NEOPLASMS; CULTURE MEDIA, CONDITIONED; CYTOSKELETAL PROTEINS; FLUOROMETRY; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; KIDNEY; LUCIFERASES; LUMINESCENT PROTEINS; MICE; NEOPLASM PROTEINS; OSTEOSARCOMA; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; RECOMBINANT FUSION PROTEINS; SACCHAROMYCES CEREVISIAE PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; WNT PROTEINS; WNT1 PROTEIN; ZEBRAFISH PROTEINS;

EID: 1842842840     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/02335dd07     Document Type: Article

References (27)

1. Burrus, L.W. and A.P. McMahon. 1995. Biochemical analysis of murine Wnt proteins reveals both shared and distinct properties. Exp. Cell Res. 220:363-373.
2. Cadigan, K.M., and R. Nusse. 1997. Wnt signaling: A common theme in animal development. Genes Dev. 11:3286-3305.
3. Da Costa, L.T., J. Jen, T.C. He, T.A. Chan, K.W. Kinzler, and B. Vogelstein. 1996. Converting cancer genes into killer genes, Proc. Natl. Acad. Sci. USA 93:4192-4196,
4. de La Coste, A., B. Romagnolo, P. Billuart, C.A. Renard, M.A. Buendia, O. Soubrane, M. Fabre, et al. 1998. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl. Acad. Sci. USA 95:8847-8851.
5. Fujimori, M., S. Ikeda, Y. Shimizu, M. Okajima, and T. Asahara. 2001. Accumulation of β-catenin protein and mutations in exon 3 of β-catenin gene in gastrointestinal carcinoid tumor. Cancer Res. 61:6656-6659.
6. Gat, U., R. DasGupta, L. Degenstein, and E. Fuchs. 1998. De novo hair follicle morphogenesis and hair tumors in mice expressing a truncated β-catenin in skin. Cell 95:605-614.
7. Harada, N., Y. Tamai, T. Ishikawa, B. Sauer, K. Takaku, M. Oshima, and M.M. Taketo. 1999. Intestinal polyposis in mice with a dominant stable mutation of the βcatenin gene. EMBO J. 18:5931-5942.
8. He, T.C., A.B. Sparks, C. Rago, H. Hermeking, L. Zawel, L.T. da Costa, P.J. Morin, B. Vogelstein, and K.W. Kinzler. 1998. Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512.
9. He, T.C., S. Zhou, L.T. da Costa, J. Yu, K.W. Kinzler, and B. Vogelstein. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95:2509-2514.
10. Kinzler, K.W. and B. Vogelstein. 1996. Lessons from hereditary colorectal cancer. Cell 87:159-170.
11. Kitajewski, J., J.O. Mason, and H.E. Varmus. 1992. Interaction of Wnt-I proteins with the binding protein BiP. Mol. Cell Biol. 12:784-790.
12. Klein, P.S. and D.A. Melton. 1996. A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. USA 93:8455-8459.
13. Krueger, S., C. Haeckel, F. Buehling, and A. Roessner. 1999. Inhibitory effects of antisense cathepsin B cDNA transfection on invasion and motility in a human osteosarcoma cell line. Cancer Res. 59:6010-6014.
14. Morin, P.J., A.B. Sparks, V. Korinek, N. Barker, H. Clevers, B. Vogelstein, and K.W. Kinzler. 1997. Activation of β-catenin-Tcf signaling in colon cancer by mutations in βcatenin or APC. Science 275:1787-1790.
15. Omholt, K., A. Platz, U. Ringborg, and J. Hansson. 2001. Cytoplasmic and nuclear accumulation of β-catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma. Int. J. Cancer 92:839-842.
16. Papkoff, J. 1989. Inducible overexpression and secretion of int-1 protein. Mol. Cell Biol. 9:3377-3384.
17. Polakis, P. 1999. The oncogenic activation of β-catenin. Curr. Opin. Genet. Dev. 9:15-21.
18. Polakis, P. 2000. Wnt signaling and cancer. Genes Dev. 14:1837-1851.
19. Rubinfeld, B., P. Robbins, M. El-Gamil, I. Albert, E. Porfiri, and P. Polakis. 1997. Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 275:1790-1792.
20. Schlosshauer, P.W., E.C. Pirog, R.L. Levine, and L.H. Ellenson. 2000. Mutational analysis of the CTNNB1 and APC genes in uterine endometrioid carcinoma. Mod. Pathol. 13:1066-1071.
21. Shinohara, A., Y. Yokoyama, X. Wan, Y. Takahashi, Y. Mori, T. Takami, K. Shimokawa, and T. Tamaya. 2001. Cytoplasmic/nuclear expression without mutation of exon 3 of the β-catenin gene is frequent in the development of the neoplasm of the uterine cervix. Gynecol. Oncol. 82:450-455.
22. Shtutman, M., J. Zhurinsky, I. Simcha, C. Albanese, M. D'Amico, R. Pestell, and A. Ben-Ze'ev. 1999. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. USA 96:5522-5527.
23. Stambolic, V., L. Ruel, and J.R. Woodgett. 1996. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr. Biol. 6:1664-1668.
24. Sugimachi, K., K. Taguchi, S. Aishima, S. Tanaka, M. Shimada, K. Kajiyama, and M. Tsuneyoshi. 2001. Altered expression of βcatenin without genetic mutation in intrahepatic cholangiocarcinoma. Mod. Pathol. 14:900-905.
25. Tetsu, O. and F. McCormick. 1999. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422-426.
26. Tsujiuchi, T., M. Tsutsumi, Y. Sasaki, N. Murata, and Y. Konishi. 2000. Mutations of adenomatous polyposis coli and β-catenin genes during progression of lung tumors induced by N-nitrosobis(2-hydroxypropyl) amine in rats. Cancer Res. 60:6611-6616.
27. Wodarz, A. and R. Nusse. 1998. Mechanisms of Wnt signaling in development. Annu. Rev. Cell Dev. Biol. 14:59-88.